Loading...
Thalidomide — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Thalidomide
2025-Q4
Comprehensive analysis of India’s thalidomide export trade — suppliers, buyers, prices, routes, and every shipment record.
71
Shipments
$81K
Trade Value
37
Suppliers
24
Buyers
28
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/thalidomide
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s thalidomide trade — 2025-Q4
KEY TAKEAWAY
Thalidomide 2025-Q4 exports total $81.5K across 28 countries, with JODAS EXPOIM PVT LTD commanding 48.0% market share.
TOTAL SHIPMENTS
71
2025-Q4
EXPORT VALUE
$81.5K
FOB USD
TOTAL QUANTITY
222.8K
units shipped
INDIAN SUPPLIERS
37
unique exporters
GLOBAL BUYERS
24
unique importers
DESTINATIONS
28
countries
MEDIAN UNIT PRICE
$1.81
per unit
TOP-5 SHARE
82.5%
of total USD
BRANDED SHARE
56.3%
40 shipments
DOSAGE FORMS
2
product types
6 KEY FINDINGS
1
JODAS EXPOIM PVT LTD is India's #1 Thalidomide exporter with $39.1K (48.0% market share).→ §5, Indian Supplier Rankings
2
Thalidomide reached 28 countries, with Sri Lanka as the top destination ($39.5K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 2790) — top 10 suppliers control 91.6% of exports.→ §5, Indian Supplier Rankings
4
91.7% of buyers (22 of 24) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Capsule dominates (95.4%) across 2 dosage forms.→ §7, Price Benchmarks
6
28 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 JODAS EXPOIM PVT LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian thalidomide exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Thalidomide report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial thalidomide trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian thalidomide suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Thalidomide India trade report
Product scope
Thalidomide
All variants merged — branded and generic formulations of thalidomide
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
71
Every commercial thalidomide trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a v-curve: Oct $45.9K, Nov $4.0K, Dec $31.5K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$45.9K
Oct USD
6 shipments
2
$4.0K
Nov USD
-91.2% MoM
3
$31.5K
Dec USD
+680.0% MoM
4
V-curve
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 91.2% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $46K, making it the strongest month by value.
Fig 3.2 Q4 cumulative USD reached $81K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $42K dip in Nov, $27K recovery in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $46K | 6 shipments |
| Nov | $4K | 18 shipments |
| Dec | $32K | 47 shipments |
| Q4 Total | $81K | 71 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Cameroon held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: JODAS EXPOIM PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import thalidomide from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Sri Lanka absorbs 48.5% of India’s 2025-Q4 thalidomide trade ($39.5K). Beyond the top 10 destinations, 28 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 11 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 28 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much thalidomide India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$49K
60.7% of trade
9 countries · 37 shipments
Europe
$3K
3.5% of trade
2 countries · 2 shipments
Americas
$22K
26.4% of trade
6 countries · 10 shipments
Africa
$8K
9.3% of trade
11 countries · 22 shipments
Fig 4.1 Sri Lanka is the #1 corridor ($40K) — 28 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian thalidomide it receives (light = low, dark = high). Orange arcs radiate from India to the top 28 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Sri Lanka | $40K | 3 | JODAS EXPOIM PVT LTD | $39K | PLEASANT EXPORTS | $448 | — | — |
| 2 | Peru | $16K | 1 | HETERO LABS LTD | $16K | — | — | — | — |
| 3 | Dominican Republic | $5K | 2 | GENEX PHARMA | $5K | — | — | — | — |
| 4 | Cameroon | $4K | 3 | NEOPHAR PHARMACEUTICALS PVT LTD | $4K | MELON GLOBALCARE | $284 | — | — |
| 5 | Thailand | $3K | 6 | SHRADDHA MEDICINES | $2K | VAMA LIFECARE PVT LTD | $498 | UNNATI PHARMAX | $431 |
| 6 | Poland | $3K | 1 | VAMA LIFECARE PVT LTD | $3K | — | — | — | — |
| 7 | Lebanon | $3K | 5 | GLOBELA PHARMA PVT LTD | $1K | MAGICINE PHARMA PVT LTD | $1K | RMPL PHARMA LLP | $209 |
| 8 | Iraq | $2K | 9 | VATS INDUSTRIES PVT LTD | $1K | ZEAL PHARMA | $785 | HEET HEALTHCARE PVT LTD | $34 |
| 9 | Equatorial Guinea | $1K | 1 | PIRZE LIFECARE PVT LTD | $1K | — | — | — | — |
| 10 | United Arab Emirates | $968 | 7 | BAKER & DAVIS PVT LTD | $703 | RMPL PHARMA LLP | $242 | HUMANKIND PHARMA | $21 |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 60.7% of USD — but Sri Lanka is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
48.5%
#1 country share
Sri Lanka alone
83.2%
Top 5 share
5 of 28 countries
99.0%
Top 15 share
Long tail of 13 countries = 1.0%
HHI 2858
Destination HHI
Highly concentrated
28
Countries served
Global pharma reach from India
11
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
37 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
JODAS EXPOIM PVT LTD ($39.1K, 48.0% share) and HETERO LABS LTD ($16.1K) together control 67.8% of India’s 2025-Q4 thalidomide trade. The top 5 suppliers hold 82.5%. 37 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian thalidomide suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 JODAS EXPOIM PVT LTD leads by $23K over HETERO LABS LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: UNNATI PHARMAX is #18 by value but #2 by volume.
Fig 5.2 ZEAL PHARMA also leads by shipment count (6) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: UNNATI PHARMAX moves from #2 by volume to #18 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 37 thalidomide suppliers split into strategic segments
KEY TAKEAWAY
10 suppliers (25%) generate 91.6% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 JODAS EXPOIM PVT LTD and HETERO LABS LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 91.6% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | JODAS EXPOIM PVT LTD | 1 | 1 | $39K |
| 2 | HETERO LABS LTD | 1 | 1 | $16K |
| 3 | GENEX PHARMA | 1 | 1 | $5K |
| 4 | NEOPHAR PHARMACEUTICALS PVT LTD | 1 | 1 | $4K |
| 5 | VAMA LIFECARE PVT LTD | 1 | 3 | $3K |
| 6 | SHRADDHA MEDICINES | 1 | 1 | $2K |
| 7 | PIRZE LIFECARE PVT LTD | 1 | 1 | $1K |
| 8 | GLOBELA PHARMA PVT LTD | 1 | 1 | $1K |
| 9 | VATS INDUSTRIES PVT LTD | 1 | 1 | $1K |
| 10 | MAGICINE PHARMA PVT LTD | 1 | 1 | $1K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the thalidomide manufacturing hubs
KEY TAKEAWAY
Siddipet Dist and Hyderabad together account for $55K of India’s 2025-Q4 thalidomide trade.
Fig 5.5 Siddipet Dist (1 exporters, $39K) and Hyderabad (1 exporters, $16K) are India’s thalidomide capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
82.5%
Top 5 share
5 of 37 suppliers
91.6%
Top 10 share
10 of 37 suppliers
91.6%
Top 25% share
10 suppliers = 92% USD
HHI 2790
Supplier HHI
Concentrated
37
Total suppliers
shipped Thalidomide in 2025-Q4
20+ cities
Indian hubs
Siddipet Dist and Hyderabad lead
§5.2 Coming next: 0 exporter deep-dive profiles
Each of the top 0 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
24 importers across 28 countries — who is buying Indian thalidomide and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 22 importers together hold only 63.3% of total USD. 92% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian thalidomide. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 SOFTCARE INTERNATIONAL(PVT)LTD is the #1 importer at $39K (48.0%) — top 22 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 22 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
92%
Single-source
22 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
4%
Multi-source (3–4)
1 buyers diversified across 3–4
4%
Broad-source (5+)
1 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source thalidomide from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Sri Lanka 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SOFTCARE INTERNATIONAL… | JODAS EXPOIM PVT LTD | $39K | $0.334 | Capsule |
| THE ESSES PHARMACY (PV… | PLEASANT EXPORTS | $448.000 | $2.987 | Capsule |
Dominican Republic 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PHARMACEUTICAL TECHNOL… | GENEX PHARMA | $5K | $3.007 | Capsule |
| PHARMACEUTICAL TECHNOL… | GENEX PHARMA | $49.511 | $0.033 | Capsule |
Thailand 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| AS PER INVOICE THAILAND | VAMA LIFECARE PVT LTD | $497.506 | $7.107 | Capsule |
| MR PAKAPON SINGKAN | UNNATI PHARMAX | $430.630 | $4.306 | Capsule |
United Arab Emirates 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ARROW TRADING FZE | BAKER & DAVIS PVT LTD | $468.206 | $1.561 | Capsule |
| ZMC EXPRESS CARGO FZCO | HUMANKIND PHARMA | $21.264 | $0.142 | Capsule |
Poland 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| AS PER INVOICE POLAND | VAMA LIFECARE PVT LTD | $3K | $5.569 | Capsule |
§6.3 Price positioning — top 22 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | SOFTCARE INTERNATION… | Sri Lanka | $39K | $20K | Mid |
| 2 | PHARMACEUTICAL TECHN… | Dominican Republic | $5K | $5K | Budget |
| 3 | AS PER INVOICE POLAND | Poland | $3K | $3K | Budget |
| 4 | CENTRAIMED | Equatorial Guinea | $1K | $1K | Budget |
| 5 | GEORGE FARAH | Lebanon | $1K | $505.000 | Budget |
| 6 | AS PER INVOICE THAIL… | Thailand | $497.506 | $498.000 | Budget |
| 7 | ARROW TRADING FZE | United Arab Emirates | $468.206 | $234.000 | Budget |
| 8 | THE ESSES PHARMACY (… | Sri Lanka | $448.000 | $448.000 | Budget |
| 9 | MR PAKAPON SINGKAN | Thailand | $430.630 | $108.000 | Budget |
| 10 | LUSAKA PHARMA CHEM S… | Zambia | $223.720 | $224.000 | Budget |
| 11 | TO THE CLINIC IN JAPAN | Japan | $211.825 | $106.000 | Budget |
| 12 | GOLD TREE PHARMACEUT… | Kenya | $209.300 | $209.000 | Budget |
| 13 | AS PER INVOICE SPA | Spain | $87.274 | $87.000 | Budget |
| 14 | PHARMACEUTICAL TECHN… | Dominican Republic | $49.511 | $50.000 | Budget |
| 15 | ATLAS TRADING COMPANY | Iraq | $34.459 | $34.000 | Budget |
| 16 | AS PER INVOICE MEXICO | Mexico | $25.513 | $26.000 | Budget |
| 17 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | $21.264 | $21.000 | Budget |
| 18 | NEW GPC INC | Guyana | $19.467 | $19.000 | Budget |
| 19 | ABU ABDU | Turkey | $18.421 | $9.000 | Budget |
| 20 | VIENG | Laos | $3.536 | $4.000 | Budget |
| 21 | AL-NOOR FOR DRUGS & … | Egypt | $1.800 | $2.000 | Budget |
| 22 | AS PER INVOICE GHANA | Ghana | $0.999 | $0.0000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 JODAS EXPOIM PVT LTD → SOFTCARE INTERNATIONAL(PVT)LTD is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian thalidomide prices vary by supplier, country and dosage form
KEY TAKEAWAY
Thalidomide prices span 3854× ($0.018 → $69.36). The coefficient of variation is 2.22. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.018 | Lowest observed unit price |
| P5 | $0.036 | 5th percentile |
| P25 | $0.389 | 25th percentile (Q1) |
| Median | $1.81 | 50th percentile (Q2) |
| P75 | $4.84 | 75th percentile (Q3) |
| P95 | $22.55 | 95th percentile |
| Max | $69.36 | Highest observed unit price |
| Mean | $5.64 | Arithmetic average |
| CV | 222% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 MAGICINE PHARMA PVT LTD prices at $56.13/unit vs market median $1.81.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. JODAS EXPOIM PVT Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. VAMA LIFECARE PVT Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. HETERO LABS LTD Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. NEOPHAR PHARMACEUTICALS PVT Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | JPC GLOBAL | Japan | Capsule | 3 | $208.07 | $69.36 | Specialty / small-batch |
| Dec 2025 | MAGICINE PHARMA … | Lebanon | Capsule | 9 | $505.15 | $56.13 | Specialty / small-batch |
| Dec 2025 | MAGICINE PHARMA … | Lebanon | Capsule | 9 | $505.15 | $56.13 | Specialty / small-batch |
| Oct 2025 | SHRADDHA MEDICINES | Thailand | Capsule | 100 | $2K | $23.04 | Specialty / small-batch |
| Dec 2025 | VAMA LIFECARE PV… | Spain | Capsule | 4 | $87.27 | $21.82 | Specialty / small-batch |
| Dec 2025 | BRINTON PHARMACE… | Saint Vincent and the Grenadines | Capsule | 6 | $75.24 | $12.54 | Specialty / small-batch |
| Dec 2025 | GLOBYZ BIOPHARMA… | United States | Capsule | 36 | $376.25 | $10.45 | Specialty / small-batch |
| Dec 2025 | BRINTON PHARMACE… | Saint Vincent and the Grenadines | Capsule | 6 | $55.59 | $9.27 | Specialty / small-batch |
| Dec 2025 | PIRZE LIFECARE P… | Equatorial Guinea | Tablet | 200 | $1K | $7.34 | Specialty / small-batch |
| Dec 2025 | VAMA LIFECARE PV… | Thailand | Capsule | 70 | $497.51 | $7.11 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | J.A. UNITED EXPO… | Egypt | Capsule | 100 | $1.80 | $0.018 | Small sample / trial shipment |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Capsule | 180 | $3.68 | $0.020 | Small sample / trial shipment |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Capsule | 720 | $14.74 | $0.020 | Small sample / trial shipment |
| Dec 2025 | GENEX PHARMA | Dominican Republic | Capsule | 1K | $49.51 | $0.033 | |
| Dec 2025 | CHAWLA MEDICOS | Laos | Capsule | 90 | $3.54 | $0.039 | Small sample / trial shipment |
| Dec 2025 | BARAKAH BIOHEALT… | Tanzania | Capsule | 20 | $0.909 | $0.045 | Small sample / trial shipment |
| Dec 2025 | RUTVA MEDICARE | Ghana | — | 20 | $0.957 | $0.048 | Small sample / trial shipment |
| Dec 2025 | SANSKRUTI PHARMA | Burkina Faso | Capsule | 90 | $4.63 | $0.051 | Small sample / trial shipment |
| Dec 2025 | VAMA HEALTH WORL… | Ghana | Capsule | 3 | $0.231 | $0.077 | Small sample / trial shipment |
| Dec 2025 | VAMA HEALTH WORL… | Ghana | Capsule | 10 | $0.769 | $0.077 | Small sample / trial shipment |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship thalidomide, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Thalidomide leaves India through 6+ ports. The top 5 (HYDERABAD AIR, MUMBAI AIR (SAHAR), DELHI AIR) handle 99.3% of total USD. AIR moves 97% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 HYDERABAD AIR handles $39K — top 6 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 COLOMBO is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 97% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$77K
94.4% of USD · 97.2% of ships
SEA
$5K
5.6% of USD · 2.8% of ships
Fig 8.3 The dominant corridor is HYDERABAD AIR → Air → Asia ($39K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Tanzania is the most concentrated destination (HHI 10000, 1 suppliers). Kenya is the most competitive (HHI 3464).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Tanzania (HHI 10,000) is the most concentrated — Kenya (HHI 3,464) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| SOFTCARE INTERNATION… | Sri Lanka | JODAS EXPOIM PVT… | $39K | 2 | MEDIUM |
| PHARMACEUTICAL TECHN… | Dominican Republic | GENEX PHARMA | $5K | 1 | MEDIUM |
| AS PER INVOICE POLAND | Poland | VAMA LIFECARE PV… | $3K | 1 | MEDIUM |
| CENTRAIMED | Equatorial Guinea | PIRZE LIFECARE P… | $1K | 1 | MEDIUM |
| GEORGE FARAH | Lebanon | MAGICINE PHARMA … | $1K | 2 | MEDIUM |
| AS PER INVOICE THAIL… | Thailand | VAMA LIFECARE PV… | $498 | 1 | MEDIUM |
| ARROW TRADING FZE | United Arab Emirates | BAKER & DAVIS PV… | $468 | 2 | MEDIUM |
| THE ESSES PHARMACY (… | Sri Lanka | PLEASANT EXPORTS | $448 | 1 | MEDIUM |
Conclusion: 22 buyers depend on exactly one Indian supplier, representing $52K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Sri Lanka | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Peru | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Dominican Republic | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Cameroon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Thailand | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Poland | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Lebanon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Iraq | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Equatorial Guinea | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Singapore | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Burkina Faso | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Zambia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Sri Lanka | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Tanzania lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Sri Lanka (2 suppliers) | This Q | HIGH |
| A6 | Enter Peru (1 suppliers) | This Q | MED |
| A8 | Build Peru distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Sri Lanka tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Sri Lanka | Asia | 2 | $40K | -98.9% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Peru | Other | 1 | $16K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Dominican Republic | Other | 1 | $5K | -98.9% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Cameroon | Africa | 2 | $4K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Thailand | Asia | 3 | $3K | -78.4% | LOW | Low competition (3 suppliers), accessible market |
| 6 | Poland | Other | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Lebanon | Other | 3 | $3K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 8 | Iraq | Other | 3 | $2K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 9 | Equatorial Guinea | Africa | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | United Arab Emirates | Other | 4 | $968 | 0% | LOW | Low competition (4 suppliers), accessible market |
| 11 | Singapore | Asia | 1 | $857 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Kenya | Africa | 3 | $715 | 0% | LOW | Low competition (3 suppliers), accessible market |
| 13 | Burkina Faso | Africa | 1 | $621 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | United States | Other | 1 | $564 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Zambia | Africa | 1 | $224 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 71 2025-Q4 Thalidomide shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/thalidomide
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 71 2025-Q4 thalidomide shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian thalidomide shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
71
across all regions
TOTAL USD
$81K
2025-Q4 FOB value
UNITS
222.8K
tablets, capsules, etc.
SUPPLIERS
37
Indian exporters
BUYERS
24
global importers
COUNTRIES
28
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $8K (9.3%), spanning 11 countries.
37 Indian suppliers shipped to 24 buyers across 28 countries — average shipment value $1K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
11 countries · 22 shipments · $8K · 14 Indian suppliers · 7 buyers
SHIPMENTS
22
USD
$8K
COUNTRIES
11
SUPPLIERS
14
BUYERS
7
HHI
3,383
concentrated
Top 11 destination countries in Africa
1
Cameroon (57.5%)
$4K
2
Equatorial Guinea (19.4%)
$1K
3
Kenya (9.4%)
$714.60
4
Burkina Faso (8.2%)
$621.17
5
Zambia (3.0%)
$223.72
6
Tanzania (1.1%)
$82.34
7
Togo (0.8%)
$58.45
8
Zimbabwe (0.5%)
$36.62
9
Ghana (0.2%)
$13.64
10
DR Congo (0.0%)
$3.45
11
Egypt (0.0%)
$1.80
Top 14 Indian suppliers into Africa
1
NEOPHAR PHARMACEUTICALS PVT LTD
$4K
2
PIRZE LIFECARE PVT LTD
$1K
3
SANSKRUTI PHARMA
$621.17
4
R.S. SURGIPHARM PVT LTD
$304.62
5
MELON GLOBALCARE
$283.93
6
MEDICOS LIFESCIENCES
$223.72
7
ASPIDA LIFE SCIENCES PVT LTD
$209.30
8
NAMAN PHARMA DRUGS
$200.67
9
BARAKAH BIOHEALTH LLP
$82.34
10
PHARMEDA HEALTHCARE PVT LTD
$58.45
11
RUTVA MEDICARE
$49.26
12
YOGI CARE PHARMACEUTICAL PVT LTD
$3.45
13
J.A. UNITED EXPORTS PVT LTD
$1.80
14
VAMA HEALTH WORLD LLP
$0.999
Top 5 Africa importers
1
CENTRAIMED · Equatorial Guinea
$1K
2
LUSAKA PHARMA CHEM SUPPLIES LTD · Zambia
$223.72
3
GOLD TREE PHARMACEUTICALS LTD · Kenya
$209.30
4
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Egypt
$1.80
5
AS PER INVOICE GHANA · Ghana
$0.999
Top 3 dosage forms
1
Capsule
$6K
2
Tablet
$1K
3
Unknown
$49.26
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $3.45 | $1.72 |
| Nov | 4 | $1K | $256.69 |
| Dec | 16 | $7K | $409.18 |
Shipment register · 22 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — NEOPHAR PHARMACEUTICALS PVT LTD · 1 shipments · $4K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Cameroon | Capsule | 1.5K | NOS | $2.71 | $4K | DELHI AIR | DOUALA | AIR |
| SUPPLIER #2 — PIRZE LIFECARE PVT LTD · 1 shipments · $1K | |||||||||||
| 2 | Dec 2025 | CENTRAIMED | Equatorial Guinea | Tablet | 200 | NOS | $7.34 | $1K | AHMEDABAD AIR | MALABO | AIR |
| SUPPLIER #3 — SANSKRUTI PHARMA · 2 shipments · $621.17 | |||||||||||
| 3 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Capsule | 135 | NOS | $4.57 | $616.54 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 4 | Dec 2025 | UNLISTED BUYER | Burkina Faso | Capsule | 90 | NOS | $0.051 | $4.63 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #4 — R.S. SURGIPHARM PVT LTD · 1 shipments · $304.62 | |||||||||||
| 5 | Dec 2025 | UNKNOWN BUYER | Kenya | Capsule | 150 | NOS | $2.03 | $304.62 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #5 — MELON GLOBALCARE · 2 shipments · $283.93 | |||||||||||
| 6 | Nov 2025 | UNLISTED BUYER | Cameroon | Capsule | 90 | NOS | $1.58 | $142.50 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| 7 | Dec 2025 | UNLISTED BUYER | Cameroon | Capsule | 90 | NOS | $1.57 | $141.44 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #6 — MEDICOS LIFESCIENCES · 1 shipments · $223.72 | |||||||||||
| 8 | Dec 2025 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | Capsule | 200 | NOS | $1.12 | $223.72 | AHMEDABAD AIR | LUSAKA | AIR |
| SUPPLIER #7 — ASPIDA LIFE SCIENCES PVT LTD · 1 shipments · $209.30 | |||||||||||
| 9 | Nov 2025 | GOLD TREE PHARMACEUTICALS LTD | Kenya | Capsule | 150 | NOS | $1.40 | $209.30 | DELHI AIR | NAIROBI | AIR |
| SUPPLIER #8 — NAMAN PHARMA DRUGS · 1 shipments · $200.67 | |||||||||||
| 10 | Dec 2025 | UNKNOWN BUYER | Kenya | Capsule | 30 | NOS | $6.69 | $200.67 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #9 — BARAKAH BIOHEALTH LLP · 3 shipments · $82.34 | |||||||||||
| 11 | Dec 2025 | UNLISTED BUYER | Tanzania | Capsule | 60 | NOS | $1.36 | $81.44 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| 12 | Dec 2025 | UNLISTED BUYER | Tanzania | Capsule | 20 | NOS | $0.045 | $0.909 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| 13 | Dec 2025 | UNLISTED BUYER | Tanzania | Capsule | 20 | NOS | $0.0000 | $0.0000 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| SUPPLIER #10 — PHARMEDA HEALTHCARE PVT LTD · 1 shipments · $58.45 | |||||||||||
| 14 | Nov 2025 | UNLISTED BUYER | Togo | Capsule | 12 | PCS | $4.87 | $58.45 | DELHI AIR | LOME | AIR |
| SUPPLIER #11 — RUTVA MEDICARE · 3 shipments · $49.26 | |||||||||||
| 15 | Dec 2025 | UNLISTED BUYER | Zimbabwe | 12 | PCS | $3.05 | $36.62 | AHMEDABAD AIR | HARARE | AIR | |
| 16 | Dec 2025 | UNLISTED BUYER | Ghana | 150 | NOS | $0.078 | $11.69 | MUMBAI AIR (SAHAR) | ACCRA | AIR | |
| 17 | Dec 2025 | UNLISTED BUYER | Ghana | 20 | NOS | $0.048 | $0.957 | MUMBAI AIR (SAHAR) | ACCRA | AIR | |
| SUPPLIER #12 — YOGI CARE PHARMACEUTICAL PVT LTD · 2 shipments · $3.45 | |||||||||||
| 18 | Oct 2025 | UNLISTED BUYER | DR Congo | Capsule | 2 | NOS | $0.862 | $1.72 | AHMEDABAD AIR | LUMBUMBASHI | AIR |
| 19 | Oct 2025 | UNLISTED BUYER | DR Congo | Capsule | 2 | NOS | $0.862 | $1.72 | AHMEDABAD AIR | LUMBUMBASHI | AIR |
| SUPPLIER #13 — J.A. UNITED EXPORTS PVT LTD · 1 shipments · $1.80 | |||||||||||
| 20 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Egypt | Capsule | 100 | NOS | $0.018 | $1.80 | MUMBAI AIR (SAHAR) | CAIRO | AIR |
| SUPPLIER #14 — VAMA HEALTH WORLD LLP · 2 shipments · $0.999 | |||||||||||
| 21 | Dec 2025 | AS PER INVOICE GHANA | Ghana | Capsule | 3 | NOS | $0.077 | $0.231 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 22 | Dec 2025 | AS PER INVOICE GHANA | Ghana | Capsule | 10 | NOS | $0.077 | $0.769 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
9 countries · 37 shipments · $49K · 17 Indian suppliers · 13 buyers
SHIPMENTS
37
USD
$49K
COUNTRIES
9
SUPPLIERS
17
BUYERS
13
HHI
6,292
concentrated
Top 9 destination countries in Asia
1
Sri Lanka (79.9%)
$40K
2
Thailand (6.5%)
$3K
3
Lebanon (5.2%)
$3K
4
Iraq (4.2%)
$2K
5
United Arab Emirates (2.0%)
$968.09
6
Singapore (1.7%)
$857.23
7
Japan (0.4%)
$211.82
8
Turkey (0.0%)
$18.42
9
Laos (0.0%)
$3.54
Top 17 Indian suppliers into Asia
1
JODAS EXPOIM PVT LTD
$39K
2
SHRADDHA MEDICINES
$2K
3
GLOBELA PHARMA PVT LTD
$1K
4
VATS INDUSTRIES PVT LTD
$1K
5
MAGICINE PHARMA PVT LTD
$1K
6
HEET HEALTHCARE PVT LTD
$891.68
7
ZEAL PHARMA
$785.46
8
BAKER & DAVIS PVT LTD
$703.31
9
VAMA LIFECARE PVT LTD
$497.51
10
RMPL PHARMA LLP
$450.67
11
PLEASANT EXPORTS
$448.00
12
UNNATI PHARMAX
$430.63
13
JPC GLOBAL
$211.82
14
HUMANKIND PHARMA
$21.26
15
AMARI TRADE ALLIANCE LLP
$18.42
16
CHAWLA MEDICOS
$3.54
17
MDS ENTERPRISES
$1.54
Top 11 Asia importers
1
SOFTCARE INTERNATIONAL(PVT)LTD · Sri Lanka
$39K
2
GEORGE FARAH · Lebanon
$1K
3
AS PER INVOICE THAILAND · Thailand
$497.51
4
ARROW TRADING FZE · United Arab Emirates
$468.21
5
THE ESSES PHARMACY (PVT) LTD · Sri Lanka
$448.00
6
MR PAKAPON SINGKAN · Thailand
$430.63
7
TO THE CLINIC IN JAPAN · Japan
$211.82
8
ATLAS TRADING COMPANY · Iraq
$34.46
9
ZMC EXPRESS CARGO FZCO · United Arab Emirates
$21.26
10
ABU ABDU · Turkey
$18.42
11
VIENG · Laos
$3.54
Top 3 dosage forms
1
Capsule
$47K
2
Tablet
$1K
3
Unknown
$857.23
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $41K | $14K |
| Nov | 13 | $3K | $230.45 |
| Dec | 21 | $5K | $242.54 |
Shipment register · 37 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — JODAS EXPOIM PVT LTD · 2 shipments · $39K | |||||||||||
| 1 | Oct 2025 | SOFTCARE INTERNATIONAL(PVT)LTD | Sri Lanka | Capsule | 21.0K | NOS | $0.198 | $4K | HYDERABAD AIR | COLOMBO | AIR |
| 2 | Oct 2025 | SOFTCARE INTERNATIONAL(PVT)LTD | Sri Lanka | Capsule | 96.0K | NOS | $0.364 | $35K | HYDERABAD AIR | COLOMBO | AIR |
| SUPPLIER #2 — SHRADDHA MEDICINES · 1 shipments · $2K | |||||||||||
| 3 | Oct 2025 | UNLISTED BUYER | Thailand | Capsule | 100 | NOS | $23.04 | $2K | AHMEDABAD AIR | BANGKOK | AIR |
| SUPPLIER #3 — GLOBELA PHARMA PVT LTD · 2 shipments · $1K | |||||||||||
| 4 | Dec 2025 | UNLISTED BUYER | Lebanon | Tablet | 167 | NOS | $4.50 | $751.50 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 5 | Dec 2025 | UNLISTED BUYER | Lebanon | Tablet | 267 | NOS | $2.25 | $600.75 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| SUPPLIER #4 — VATS INDUSTRIES PVT LTD · 2 shipments · $1K | |||||||||||
| 6 | Nov 2025 | UNKNOWN BUYER | Iraq | Capsule | 300 | NOS | $2.10 | $631.40 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| 7 | Nov 2025 | UNKNOWN BUYER | Iraq | Capsule | 300 | NOS | $2.10 | $631.40 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #5 — MAGICINE PHARMA PVT LTD · 2 shipments · $1K | |||||||||||
| 8 | Dec 2025 | GEORGE FARAH | Lebanon | Capsule | 9 | NOS | $56.13 | $505.15 | DELHI AIR | BEIRUT | AIR |
| 9 | Dec 2025 | GEORGE FARAH | Lebanon | Capsule | 9 | PCS | $56.13 | $505.15 | DELHI AIR | BEIRUT | AIR |
| SUPPLIER #6 — HEET HEALTHCARE PVT LTD · 3 shipments · $891.68 | |||||||||||
| 10 | Nov 2025 | ATLAS TRADING COMPANY | Iraq | Capsule | 15 | NOS | $2.30 | $34.46 | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| 11 | Dec 2025 | UNLISTED BUYER | Singapore | 150 | NOS | $1.22 | $183.69 | AHMEDABAD AIR | SINGAPORE | AIR | |
| 12 | Dec 2025 | UNLISTED BUYER | Singapore | 300 | NOS | $2.25 | $673.53 | AHMEDABAD AIR | SINGAPORE | AIR | |
| SUPPLIER #7 — ZEAL PHARMA · 6 shipments · $785.46 | |||||||||||
| 13 | Nov 2025 | UNLISTED BUYER | Iraq | Capsule | 150 | NOS | $1.81 | $271.69 | MUMBAI AIR (SAHAR) | BAGDAD, METROPOLITAN | AIR |
| 14 | Nov 2025 | UNLISTED BUYER | Iraq | Capsule | 150 | NOS | $1.81 | $271.69 | MUMBAI AIR (SAHAR) | BAGDAD, METROPOLITAN | AIR |
| 15 | Dec 2025 | UNLISTED BUYER | Iraq | Capsule | 30 | NOS | $1.56 | $46.77 | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| 16 | Dec 2025 | UNLISTED BUYER | Iraq | Capsule | 60 | NOS | $1.24 | $74.28 | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| 17 | Dec 2025 | UNLISTED BUYER | Iraq | Capsule | 30 | NOS | $1.56 | $46.77 | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| 18 | Dec 2025 | UNLISTED BUYER | Iraq | Capsule | 60 | NOS | $1.24 | $74.28 | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #8 — BAKER & DAVIS PVT LTD · 3 shipments · $703.31 | |||||||||||
| 19 | Nov 2025 | ARROW TRADING FZE | United Arab Emirates | Capsule | 150 | NOS | $1.55 | $233.10 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 20 | Nov 2025 | ARROW TRADING FZE | United Arab Emirates | Capsule | 150 | NOS | $1.57 | $235.11 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 21 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Capsule | 150 | NOS | $1.57 | $235.11 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #9 — VAMA LIFECARE PVT LTD · 1 shipments · $497.51 | |||||||||||
| 22 | Dec 2025 | AS PER INVOICE THAILAND | Thailand | Capsule | 70 | NOS | $7.11 | $497.51 | MUMBAI AIR (SAHAR) | BANGKOK | AIR |
| SUPPLIER #10 — RMPL PHARMA LLP · 2 shipments · $450.67 | |||||||||||
| 23 | Dec 2025 | UNLISTED BUYER | Lebanon | Capsule | 50 | NOS | $4.17 | $208.69 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 24 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Capsule | 50 | NOS | $4.84 | $241.98 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
| SUPPLIER #11 — PLEASANT EXPORTS · 1 shipments · $448.00 | |||||||||||
| 25 | Dec 2025 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | Capsule | 150 | NOS | $2.99 | $448.00 | CHENNAI AIR | COLOMBO | AIR |
| SUPPLIER #12 — UNNATI PHARMAX · 4 shipments · $430.63 | |||||||||||
| 26 | Nov 2025 | MR PAKAPON SINGKAN | Thailand | Capsule | 30 | NOS | $3.90 | $117.10 | MUMBAI AIR (SAHAR) | BANGKOK | AIR |
| 27 | Nov 2025 | MR PAKAPON SINGKAN | Thailand | Capsule | 20 | NOS | $4.91 | $98.21 | MUMBAI AIR (SAHAR) | BANGKOK | AIR |
| 28 | Nov 2025 | MR PAKAPON SINGKAN | Thailand | Capsule | 30 | NOS | $3.90 | $117.10 | MUMBAI AIR (SAHAR) | BANGKOK | AIR |
| 29 | Nov 2025 | MR PAKAPON SINGKAN | Thailand | Capsule | 20 | NOS | $4.91 | $98.21 | MUMBAI AIR (SAHAR) | BANGKOK | AIR |
| SUPPLIER #13 — JPC GLOBAL · 2 shipments · $211.82 | |||||||||||
| 30 | Dec 2025 | TO THE CLINIC IN JAPAN | Japan | Capsule | 10 | PCS | $0.376 | $3.76 | MUMBAI AIR (SAHAR) | TOKYO | AIR |
| 31 | Dec 2025 | TO THE CLINIC IN JAPAN | Japan | Capsule | 3 | PCS | $69.36 | $208.07 | MUMBAI AIR (SAHAR) | TOKYO | AIR |
| SUPPLIER #14 — HUMANKIND PHARMA · 1 shipments · $21.26 | |||||||||||
| 32 | Nov 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Capsule | 150 | NOS | $0.142 | $21.26 | MUMBAI AIR (SAHAR) | DUBAI WORLD CENTRAL | AIR |
| SUPPLIER #15 — AMARI TRADE ALLIANCE LLP · 2 shipments · $18.42 | |||||||||||
| 33 | Dec 2025 | ABU ABDU | Turkey | Capsule | 180 | NOS | $0.020 | $3.68 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 34 | Dec 2025 | ABU ABDU | Turkey | Capsule | 720 | NOS | $0.020 | $14.74 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #16 — CHAWLA MEDICOS · 1 shipments · $3.54 | |||||||||||
| 35 | Dec 2025 | VIENG | Laos | Capsule | 90 | PCS | $0.039 | $3.54 | DELHI AIR | VIENTIANE | AIR |
| SUPPLIER #17 — MDS ENTERPRISES · 2 shipments · $1.54 | |||||||||||
| 36 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 10 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 37 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 10 | NOS | $0.154 | $1.54 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
2 countries · 2 shipments · $3K · 1 Indian suppliers · 2 buyers
SHIPMENTS
2
USD
$3K
COUNTRIES
2
SUPPLIERS
1
BUYERS
2
HHI
10,000
concentrated
Top 2 destination countries in Europe
1
Poland (97.0%)
$3K
2
Spain (3.0%)
$87.27
Top 1 Indian suppliers into Europe
1
VAMA LIFECARE PVT LTD
$3K
Top 2 Europe importers
1
AS PER INVOICE POLAND · Poland
$3K
2
AS PER INVOICE SPA · Spain
$87.27
Top 1 dosage forms
1
Capsule
$3K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 2 | $3K | $1K |
Shipment register · 2 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — VAMA LIFECARE PVT LTD · 2 shipments · $3K | |||||||||||
| 1 | Dec 2025 | AS PER INVOICE POLAND | Poland | Capsule | 500 | NOS | $5.57 | $3K | MUMBAI AIR (SAHAR) | WARSAW | AIR |
| 2 | Dec 2025 | AS PER INVOICE SPA | Spain | Capsule | 4 | NOS | $21.82 | $87.27 | MUMBAI AIR (SAHAR) | MADRID | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
6 countries · 10 shipments · $22K · 7 Indian suppliers · 5 buyers
SHIPMENTS
10
USD
$22K
COUNTRIES
6
SUPPLIERS
7
BUYERS
5
HHI
6,057
concentrated
Top 6 destination countries in Americas
1
Peru (74.8%)
$16K
2
Dominican Republic (21.1%)
$5K
3
United States (2.6%)
$564.38
4
Mexico (0.7%)
$147.90
5
Saint Vincent and the Grenadines (0.6%)
$130.83
6
Guyana (0.1%)
$19.47
Top 7 Indian suppliers into Americas
1
HETERO LABS LTD
$16K
2
GENEX PHARMA
$5K
3
GLOBYZ BIOPHARMA PVT LTD
$564.38
4
BRINTON PHARMACEUTICALS LTD
$130.83
5
MEDINEX HEALTHCARE
$122.38
6
VAMA HEALTH WORLD LLP
$25.51
7
H V A INTERNATIONAL
$19.47
Top 4 Americas importers
1
PHARMACEUTICAL TECHNOLOGYCALLE DESI · Dominican Republic
$5K
2
PHARMACEUTICAL TECHNOLOGY · Dominican Republic
$49.51
3
AS PER INVOICE MEXICO · Mexico
$25.51
4
NEW GPC INC · Guyana
$19.47
Top 2 dosage forms
1
Capsule
$22K
2
Tablet
$19.47
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $5K | $5K |
| Nov | 1 | $19.47 | $19.47 |
| Dec | 8 | $17K | $2K |
Shipment register · 10 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — HETERO LABS LTD · 1 shipments · $16K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Peru | Capsule | 95.0K | NOS | $0.170 | $16K | MUMBAI AIR (SAHAR) | LIMA - | AIR |
| SUPPLIER #2 — GENEX PHARMA · 2 shipments · $5K | |||||||||||
| 2 | Oct 2025 | PHARMACEUTICAL TECHNOLOGYCALLE DESI | Dominican Republic | Capsule | 1.5K | NOS | $3.01 | $5K | NHAVA SHEVA SEA (JNPT) | CAUCEDO DOMINIC REP. | SEA |
| 3 | Dec 2025 | PHARMACEUTICAL TECHNOLOGY | Dominican Republic | Capsule | 1.5K | NOS | $0.033 | $49.51 | NHAVA SHEVA SEA (JNPT) | CAUCEDO DOMINIC REP. | SEA |
| SUPPLIER #3 — GLOBYZ BIOPHARMA PVT LTD · 2 shipments · $564.38 | |||||||||||
| 4 | Dec 2025 | UNLISTED BUYER | United States | Capsule | 36 | NOS | $5.23 | $188.13 | MUMBAI AIR (SAHAR) | MIAMI, FL | AIR |
| 5 | Dec 2025 | UNLISTED BUYER | United States | Capsule | 36 | NOS | $10.45 | $376.25 | MUMBAI AIR (SAHAR) | MIAMI, FL | AIR |
| SUPPLIER #4 — BRINTON PHARMACEUTICALS LTD · 2 shipments · $130.83 | |||||||||||
| 6 | Dec 2025 | UNLISTED BUYER | Saint Vincent and the Grenadines | Capsule | 6 | NOS | $9.27 | $55.59 | MUMBAI AIR (SAHAR) | ST VINCENT | AIR |
| 7 | Dec 2025 | UNLISTED BUYER | Saint Vincent and the Grenadines | Capsule | 6 | NOS | $12.54 | $75.24 | MUMBAI AIR (SAHAR) | ST VINCENT | AIR |
| SUPPLIER #5 — MEDINEX HEALTHCARE · 1 shipments · $122.38 | |||||||||||
| 8 | Dec 2025 | UNLISTED BUYER | Mexico | Capsule | 20 | NOS | $6.12 | $122.38 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #6 — VAMA HEALTH WORLD LLP · 1 shipments · $25.51 | |||||||||||
| 9 | Dec 2025 | AS PER INVOICE MEXICO | Mexico | Capsule | 25 | NOS | $1.02 | $25.51 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #7 — H V A INTERNATIONAL · 1 shipments · $19.47 | |||||||||||
| 10 | Nov 2025 | NEW GPC INC | Guyana | Tablet | 50 | NOS | $0.389 | $19.47 | MUMBAI AIR (SAHAR) | GEORGETOWN | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 37 Indian thalidomide exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped thalidomide in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | JODAS EXPOIM PVT LTD | SIDDIPET DIST | 2 | $39K | Capsule | Asia |
| 2 | HETERO LABS LTD | HYDERABAD | 1 | $16K | Capsule | Americas |
| 3 | GENEX PHARMA | MUMBAI / MAHARASHTRA | 2 | $5K | Capsule | Americas |
| 4 | NEOPHAR PHARMACEUTICALS PVT LTD | DELHI | 1 | $4K | Capsule | Africa |
| 5 | VAMA LIFECARE PVT LTD | MUMBAI | 3 | $3K | Capsule | Europe, Asia |
| 6 | SHRADDHA MEDICINES | RAJKOT/GUJARAT | 1 | $2K | Capsule | Asia |
| 7 | PIRZE LIFECARE PVT LTD | AHMEDABAD | 1 | $1K | Tablet | Africa |
| 8 | GLOBELA PHARMA PVT LTD | SURAT | 2 | $1K | Tablet | Asia |
| 9 | VATS INDUSTRIES PVT LTD | DDA SHED | 2 | $1K | Capsule | Asia |
| 10 | MAGICINE PHARMA PVT LTD | New Delhi | 2 | $1K | Capsule | Asia |
| 11 | HEET HEALTHCARE PVT LTD | AHMEDABAD | 3 | $891.68 | Capsule | Asia |
| 12 | ZEAL PHARMA | NEW KOSAD ROAD AMROLI | 6 | $785.46 | Capsule | Asia |
| 13 | BAKER & DAVIS PVT LTD | MUMBAI | 3 | $703.31 | Capsule | Asia |
| 14 | SANSKRUTI PHARMA | SURAT | 2 | $621.17 | Capsule | Africa |
| 15 | GLOBYZ BIOPHARMA PVT LTD | MUMBAI | 2 | $564.38 | Capsule | Americas |
| 16 | RMPL PHARMA LLP | MUMBAI | 2 | $450.67 | Capsule | Asia |
| 17 | PLEASANT EXPORTS | CHENNAI | 1 | $448.00 | Capsule | Asia |
| 18 | UNNATI PHARMAX | Nagpur | 4 | $430.63 | Capsule | Asia |
| 19 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 1 | $304.62 | Capsule | Africa |
| 20 | MELON GLOBALCARE | MUMBAI | 2 | $283.93 | Capsule | Africa |
| 21 | MEDICOS LIFESCIENCES | AHMEDABAD | 1 | $223.72 | Capsule | Africa |
| 22 | JPC GLOBAL | MUMBAI | 2 | $211.82 | Capsule | Asia |
| 23 | ASPIDA LIFE SCIENCES PVT LTD | GHAZIABAD | 1 | $209.30 | Capsule | Africa |
| 24 | NAMAN PHARMA DRUGS | MUMBAI | 1 | $200.67 | Capsule | Africa |
| 25 | BRINTON PHARMACEUTICALS LTD | PUNE | 2 | $130.83 | Capsule | Americas |
| 26 | MEDINEX HEALTHCARE | Mumbai | 1 | $122.38 | Capsule | Americas |
| 27 | BARAKAH BIOHEALTH LLP | Tiruppur | 3 | $82.34 | Capsule | Africa |
| 28 | PHARMEDA HEALTHCARE PVT LTD | NEW DELHI | 1 | $58.45 | Capsule | Africa |
| 29 | RUTVA MEDICARE | SURAT | 3 | $49.26 | Africa | |
| 30 | VAMA HEALTH WORLD LLP | Mumbai | 3 | $26.51 | Capsule | Americas, Africa |
| 31 | HUMANKIND PHARMA | Mumbai | 1 | $21.26 | Capsule | Asia |
| 32 | H V A INTERNATIONAL | VILE PARLE EAST | 1 | $19.47 | Tablet | Americas |
| 33 | AMARI TRADE ALLIANCE LLP | MUMBAI | 2 | $18.42 | Capsule | Asia |
| 34 | CHAWLA MEDICOS | NEW DELHI | 1 | $3.54 | Capsule | Asia |
| 35 | YOGI CARE PHARMACEUTICAL PVT LTD | AHMEDABAD | 2 | $3.45 | Capsule | Africa |
| 36 | J.A. UNITED EXPORTS PVT LTD | VASHI | 1 | $1.80 | Capsule | Africa |
| 37 | MDS ENTERPRISES | MUMBAI | 2 | $1.54 | Tablet | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 22 global thalidomide importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian thalidomide in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | SOFTCARE INTERNATIONAL(PVT)LTD | Sri Lanka | 2 | $39K | JODAS EXPOIM PVT LTD | Capsule |
| 2 | PHARMACEUTICAL TECHNOLOGYCALLE DESI | Dominican Republic | 1 | $5K | GENEX PHARMA | Capsule |
| 3 | AS PER INVOICE POLAND | Poland | 1 | $3K | VAMA LIFECARE PVT LTD | Capsule |
| 4 | CENTRAIMED | Equatorial Guinea | 1 | $1K | PIRZE LIFECARE PVT LTD | Tablet |
| 5 | GEORGE FARAH | Lebanon | 2 | $1K | MAGICINE PHARMA PVT … | Capsule |
| 6 | AS PER INVOICE THAILAND | Thailand | 1 | $497.51 | VAMA LIFECARE PVT LTD | Capsule |
| 7 | ARROW TRADING FZE | United Arab Emirates | 2 | $468.21 | BAKER & DAVIS PVT LTD | Capsule |
| 8 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | 1 | $448.00 | PLEASANT EXPORTS | Capsule |
| 9 | MR PAKAPON SINGKAN | Thailand | 4 | $430.63 | UNNATI PHARMAX | Capsule |
| 10 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | 1 | $223.72 | MEDICOS LIFESCIENCES | Capsule |
| 11 | TO THE CLINIC IN JAPAN | Japan | 2 | $211.82 | JPC GLOBAL | Capsule |
| 12 | GOLD TREE PHARMACEUTICALS LTD | Kenya | 1 | $209.30 | ASPIDA LIFE SCIENCES… | Capsule |
| 13 | AS PER INVOICE SPA | Spain | 1 | $87.27 | VAMA LIFECARE PVT LTD | Capsule |
| 14 | PHARMACEUTICAL TECHNOLOGY | Dominican Republic | 1 | $49.51 | GENEX PHARMA | Capsule |
| 15 | ATLAS TRADING COMPANY | Iraq | 1 | $34.46 | HEET HEALTHCARE PVT … | Capsule |
| 16 | AS PER INVOICE MEXICO | Mexico | 1 | $25.51 | VAMA HEALTH WORLD LLP | Capsule |
| 17 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | 1 | $21.26 | HUMANKIND PHARMA | Capsule |
| 18 | NEW GPC INC | Guyana | 1 | $19.47 | H V A INTERNATIONAL | Tablet |
| 19 | ABU ABDU | Turkey | 2 | $18.42 | AMARI TRADE ALLIANCE… | Capsule |
| 20 | VIENG | Laos | 1 | $3.54 | CHAWLA MEDICOS | Capsule |
| 21 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Egypt | 1 | $1.80 | J.A. UNITED EXPORTS … | Capsule |
| 22 | AS PER INVOICE GHANA | Ghana | 2 | $0.999 | VAMA HEALTH WORLD LLP | Capsule |
This report covers 71 2025-Q4 Thalidomide shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/thalidomide
Talk to our trade analyst
Need a custom thalidomide report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/thalidomide
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Thalidomide product page
Live data, supplier directory, price trends, and trade route analysis